BioSpace News Archive

Business

Merck Makes Another Big R&D Investment with $3.5B Orna Deal

Merck and Orna will explore various therapeutic and vaccine programs in a collaboration worth a potential $3.5 billion.

August 16, 2022
·
3 min read
·
Vanessa Doctor, RN and Heather McKenzie
Business

Senda Biosciences Scores $226M to Advance Programmable Medicines Platform

Proceeds from the fund activities will be used to back Senda’s proprietary programmable medicines platform and advance its projects to clinical trial stages.

August 16, 2022
·
2 min read
·
Vanessa Doctor, RN
Drug Development

Clene to Move Forward in MS Despite COVID-19-Halted Phase II Trial

Clene Nanomedicine’s CNM-Au8 demonstrated surprising improvements in some MS patients, despite the study being halted early due to COVID-19.

August 16, 2022
·
4 min read
·
Alex Keown
Deals

Investors Continue to Fund Data Over Ideas In Current Biotech Downturn

BioSpace spoke with industry executives and investors about the current economic situation in the biotech industry and sourced tips on how leaders can weather the downturn.

August 16, 2022
·
4 min read
·
Gail Dutton
Policy

COVID-19: Novavax Seeks EUA for Booster, TB Vaccine may Hold Promise and More

Novavax seeks EUA for COVID-19 Booster, a 100-year-old TB vaccine may protect against the disease and public health officials struggle with fall planning.

August 16, 2022
·
5 min read
·
Mark Terry
Policy

FDA Clock Starts for AstraZeneca and Merck in Prostate Cancer, Roche in DLBCL

The FDA has accepted the sNDA for AstraZeneca and Merck’s Lynparza and the sBLA for Genentech (Roche)'s for Polivy in diffuse large B-cell lymphoma.

August 16, 2022
·
3 min read
·
Tristan Manalac
Drug Development

Gilead’s Trodelvy Gives Enhertu a Run for its Money in Metastatic Breast Cancer

Weeks after AstraZeneca and Daiichi Sankyo were able to move the bar in the treatment of metastatic breast cancer with Enhertu, Gilead is answering that challenge with Trodelvy.

August 16, 2022
·
3 min read
·
Alex Keown
Policy

South Korea Memorandum Latest in Gates Foundation’s Efforts to Solve Global Health

The Bill & Melinda Gates Foundation inked a memorandum of understanding with South Korea’s foreign and health ministries to expand their partnerships revolving around public health.

August 16, 2022
·
4 min read
·
Mark Terry
Study: Link Between NRG4 Protein and NASH could Open Therapeutic Avenues

Researchers found promising connections between the Neuregulin 4 (NRG4) endocrine factor protein and the suppression of specific liver diseases, including NASH.

August 16, 2022
·
3 min read
·
Katherine Davis
First Aid Kits Market is Projected to Experience Promising Growth Opportunities in the Forthcoming Years

Wilmington, Delaware, United States, Transparency Market Research Inc. – An emergency aid or treatment given to an individual who is injured or affected with a sudden illness, before the arrival of regular medical services can be termed as first aid.

August 16, 2022
·
5 min read